Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07825454 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pilot Study of Hydroxychloroquine for the Treatment of AIMSS

Name: Pilot Study of Hydroxychloroquine for the Treatment of AIMSS — clinical trial record (NCT07825454)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: AIMSS

StatusNot Yet Recruiting

PhasePhase 2

SponsorIndiana University

Started2026-09

View on ClinicalTrials.gov ↗

Indiana University

306 trials monitored

See 37 trials at risk

Breast Cancer

5,176 trials monitored

See 251 trials at risk

The purpose of this study is to evaluate the effectiveness of hydroxychloroquine sulfate (a type of drug commonly used to treat joint pain caused by inflammation, swelling) in reducing joint pain associated with Aromatase Inhibitor Associated Musculoskeletal Syndrome (AIMSS) for patients with breast cancer.

Trial Details

NCT Number	NCT07825454
Lead Sponsor	Indiana University Collaborators: 100 Voices of Hope
Conditions	Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS), Joint Pain, Breast Cancer
Enrollment	35 participants
Start Date	2026-09
Primary Completion	2029-12 (estimated)
Study Completion	2029-12 (estimated)
Updated on ClinicalTrials.gov	2026-09-17